← Leaderboards
Yosef Refaeli
National Jewish Health
$4,091,114
Attributed
$5,946,881
Total exposure
8
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2006–15$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$5,946,881 · 8
By mechanism
R01$3,080,806 · 2
R44$1,419,863 · 1
P01$781,145 · 1
R43$665,067 · 4
Top collaborators
- Brian Curtis Turner6 shared
- Dennis Roop5 shared
Most similar at National Jewish Health
Same institution · by research overlap
- Claude A Piantadosi$13,955,144
- John C. Cambier$24,404,039
- Gary L. Johnson$39,128,449
- Robert James Mason$10,199,421
- G Scott Worthen$17,039,709
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsBaseGenesGeneticImmuneProgramsGenerationsResearch PersonnelB-LymphocytesPhenotypeSignal TransductionTechnologyLymphocyteHematopoietic Stem CellsImmune ResponseCell LineProductionResponseAutoreactive B CellHomeostasisMediatingMemberAnimalsNew Technology
Grant awards (21)
The consequences of loricrin deficiency on epidermal barrier function$329,940
R01 · FY2015 · AR
The consequences of loricrin deficiency on epidermal barrier function$323,341
R01 · FY2014 · AR
The consequences of loricrin deficiency on epidermal barrier function$313,443
R01 · FY2013 · AR
The consequences of loricrin deficiency on epidermal barrier function$329,940
R01 · FY2012 · AR
Generation of HIV resistant cells from protein transduced hematopoetic stem cell$759,221
R44 · FY2011 · HL
The consequences of loricrin deficiency on epidermal barrier function$329,940
R01 · FY2011 · AR
Genetics$156,792
P01 · FY2011 · AI · contact PI
Generation of HIV resistant cells from protein transduced hematopoetic stem cell$660,642
R44 · FY2010 · HL
MYC-induced breach of B-cell anergy in AIDS-related NHLs$359,925
R01 · FY2010 · CA · contact PI
Molecular based strategies to generate protective immune responses to HIV-1$171,767
R43 · FY2010 · AI
Genetics$161,238
P01 · FY2010 · AI · contact PI
Large-scale generation of human red blood cells for transfusion therapy$151,441
R43 · FY2010 · HL
MYC-induced breach of B-cell anergy in AIDS-related NHLs$361,101
R01 · FY2009 · CA · contact PI
Genetics$156,591
P01 · FY2009 · AI · contact PI
MYC-induced breach of B-cell anergy in AIDS-related NHLs$241,983
R01 · FY2008 · CA · contact PI
Rapid Generation of Human Therapuetic Antibodies Against Influenza$180,667
R43 · FY2008 · AI
Generating HIV resistant cells from conditionally transformed HSC cell lines$161,192
R43 · FY2008 · HL
Genetics$153,619
P01 · FY2008 · AI · contact PI
MYC-induced breach of B-cell anergy in AIDS-related NHLs$241,983
R01 · FY2007 · CA · contact PI
Genetics$152,905
P01 · FY2007 · AI · contact PI
MYC-induced breach of B-cell anergy in AIDS-related NHLs$249,210
R01 · FY2006 · CA · contact PI